Founded with the mission to revolutionize the manufacturing, storage, and delivery of vaccines and biologics, Jurata Thin Film focuses on enabling long-term storage at ambient or elevated temperatures. Their innovative thin film technology allows for versatile administration routes, making vaccines and therapeutics more accessible globally. By addressing the critical challenges of vaccine stability and distribution, Jurata aims to enhance public health outcomes worldwide.
Jurata Thin Film's team comprises experts with extensive experience in developing cutting-edge technologies. The company has garnered attention for its potential to transform vaccine logistics, particularly in regions lacking cold chain infrastructure. Notable achievements include successful stabilization of various biologics, positioning Jurata as a key player in the biotech industry. Their impact is significant, promising to improve vaccine accessibility and efficacy on a global scale.
